P068 DUPILUMAB REDUCES BIOMARKERS OF TYPE 2 INFLAMMATION IN CHILDREN WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA

Authors :: Leonard B. Bacharier
Constance H. Katelaris
Megan Hardin
D. Lederer
Jorge Maspero
Alessandro Fiocchi
D. Liu
Source :: Annals of Allergy, Asthma & Immunology. 127:S33
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Pulmonary and Respiratory Medicine
Moderate to severe
business.industry
Immunology
medicine
Immunology and Allergy
Inflammation
medicine.symptom
business
medicine.disease
Dupilumab
Asthma

Full Text Access

Tools